Immunomic TherapeuticsImmunomic Therapeutics
Immunomic TherapeuticsImmunomic Therapeutics
  • Technology
  • Partnerships
  • Clinical Trials
  • People
  • Careers
  • Media
  • Contact Us
  • Technology
  • Partnerships
  • Clinical Trials
  • People
  • Careers
  • Media
  • Contact Us

Articles

Articles

  • Highlights
  • Events
  • Blog
  • News
  • Articles
  • Press Releases
  • The Use and Misuse of Cancer Life Expectancy Statistics

    Articles Blog Featured Highlights
    Please read the article authored by ITI titled, “The Use and Misuse of Cancer Life Expectancy Statistics” which explores how GBM patients adjust and deal with dire life expectancy statistics.
    Read more
  • Glioblastoma topples an American hero, but researchers will continue the fight, article by Dr. Duane Mitchell, University of Florida

    Articles Blog
    Senator McCain fought glioblastoma bravely. Our team, and scientists around the world, remain committed to researching treatment options.  Read Dr. Mitchell's article on the progress being made in the treatment
    Read more
  • In Vivo - Pharma intelligence

    In Vivo’s William Looney Interviews CEO, Bill Hearl As Part of a Recent Feature on Cancer Vaccines

    Articles Blog Highlights
    In Vivo feature titled, Cancer Vaccines: Is There A Future Beyond Trial And Error? While it has been a challenging R&D field, Looney notes that several key advances may soon
    Read more
  • Raising Awareness for Brain Tumor Research

    Articles Blog Featured
    May is Brain Tumor Awareness Month. In the United States, an estimated 700,000 people are living with a primary brain tumor and 79,000 more will be diagnosed this year. Gliomas
    Read more
  • Biotech Goes to Broadway

    Articles Highlights
    Scientific American’s Custom Media division hosted a unique salon-style event in collaboration with Immunomic Therapeutics on Monday, February 12th in the heart of Manhattan’s Times Square. The forum, Hot Topics in Biotech:
    Read more
  • How Astellas is Working to Change Allergy Prevention through Partnership with Immunomic Therapeutics

    Articles Featured Highlights
    Read how Astellas is working to address a high unmet medical need with first-of-its-kind allergy vaccine development through an innovative partnership. The following article was authored by Astellas and published on
    Read more
  • The Fight Against Cancer Is Increasingly Personal

    Articles Highlights Press
    Scientific American custom media and Immunomic Therapeutics released an article titled, “The Fight Against Cancer is Increasingly Personal,” by reclassifying tumors, scientists are finding a path to genuine cancer cures.
    Read more
  • Logo - The Baltimore Sun

    Md. is developing the next generation of life-saving vaccines

    Articles Blog Press
    Sia Anagnostou, Senior Director at Immunomic Therapeutics authored this article, "Md. is developing the next generation of life-saving vaccines" in the Baltimore Sun. http://www.baltimoresun.com/news/opinion/oped/bs-ed-op-1020-vaccines-md-20171018-story.html  
    Read more
  • What’s Behind the Fear of Vaccines?

    Articles Blog Featured
    A closer look at the social, cultural and political issues influencing immunization This article was produced for Immunomic Therapeutics by Scientific American Custom Media, a division separate from the magazine’s board of editors.
    Read more
  • DNA VACCINE TECHNOLOGY – A Vaccine Breakthrough That Could Change Lives & Enable Vaccine Development Programs

    Articles Highlights Press
    http://www.drug-dev.com/Main/Back-Issues/DNA-VACCINE-TECHNOLOGY-A-Vaccine-Breakthrough-That-981.aspx INTRODUCTION What if there was the potential for a better and safer treatment for allergies, a less-toxic cancer therapy, or a breakthrough treatment to improve the health of a
    Read more
  • Immunomic Negotiates License to Trianni Mouse for Human Antibody Discovery

    Articles
    https://www.genengnews.com/gen-news-highlights/immunomic-negotiates-license-to-trianni-mouse-for-human-antibody-discovery/81254369 Immunomic Negotiates License to Trianni Mouse for Human Antibody Discovery Trianni granted Immunomic Therapeutics a license to its Trianni Mouse™ platform for generating fully human antibodies. Immunomic said it
    Read more
  • Vaccines Based on Immunotherapies Being Tested in Phase 2 Trials in Brain Cancer

    Articles
    https://immuno-oncologynews.com/2017/05/18/cancer-vaccine-based-on-immunotherapy-combo-by-immunomic-therapeutics-enters-trial-in-brain-cancer/ BY PATRICIA INACIO, PHD Immunomic Therapeutics has entered an exclusive licensing agreement with Annias Immunotherapeutics for the rights to use Annia’s intellectual property regarding an immunotherapy based on antigens
    Read more
12
Next page →


Content
  • Technology
  • Partnerships
  • People
  • Media
  • Contact Us
Careers
  • Careers
  • Compensation & Benefits
  • Culture & Beliefs
Social
  • Facebook
  • Twitter
  • Google+
  • LinkedIn
  • Youtube
Telephone
+1.301.968.3501

Address
15010 Broschart Road Suite 250
Rockville, MD 20850

© 2017 Immunomic Therapeutics, Inc. All Rights Reserved.